Last reviewed · How we verify

NCT04678141

Clinical Evaluation of Compomer and Composite Class II Restorations in Primary Molars: 24 Months Results

Completed NA Last updated 20 July 2022
What this trial tests

NA trial testing Dyract XP (Dentsply De Trey), Kerr Herculite Classic (Kerr Corporation),R&D Series NOVA(Kuraray Medical Inc) Clearfil TM SE Bond (Kuraray Medical),Hydrocal LC (Medicept Dental) in Primary Teeth in 145 participants. Completed in 23 August 2020.

Timeline
23 July 2018
Primary endpoint
23 October 2018
23 August 2020

Quick facts

Lead sponsorSuleyman Demirel University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment145
Start date23 July 2018
Primary completion23 October 2018
Estimated completion23 August 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Suleyman Demirel University

Who can join

Adults 5 to 6, any sex, with Primary Teeth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It was aimed to evaluate the clinical performance of resin-hybrid composite and compomer materials in primary molars over a 2-year period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Primary Teeth

Currently open trials in the same condition.

Other Suleyman Demirel University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04678141.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing